Applied in a vaccination program, the 7-valent pneumococcal conjugate vaccine (PCV7) in a 2+1 dose schedule appears to be highly effective. Conjugate vaccines with more than seven serotypes will ...

Although the effect of heptavalent pneumococcal conjugate vaccine (PCV7) has been demonstrated in all pre-registration and postmarketing studies, its real effect on the incidence of AOM cannot be ...

Sanofi has moved ahead with plans to challenge Pfizer and MSD for a piece of the market for pneumococcal ... of innovative work in PCV," remarked Sanofi's head of vaccines, Thomas Triomphe.

The Odessa American is the leading source of local news, information, entertainment and sports for the Permian Basin.

Vaxcyte's new pneumococcal vaccine may only have phase 1/2 results behind it, but analysts are already predicting it could be a major competitor to rival shots from Pfizer and MSD. Just-reported ...

As measles cases continue to crop up across the U.S., so too are cases of another highly contagious disease. Whooping cough, ...

The Tetanus, Diphtheria, Pertussis vaccine, known as Tdap, is designed to be given to adults, teens and children over the age of 7. Protection given by the vaccine does lessen over time ...